Bristol-Myers Squibb made an offer today to purchase Imclone Systems for $60 per share or $4.5 billion in cash. Bristol already owns about 17 percent of Imclone so today’s offer values Imclone at $5.2 billion.
The offer was a 30 percent premium over Wednesday’s closing price of $46.44 per share. Shares of Imclone closed at $63.93, [...]

Continue reading ...